Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The test, which was granted Breakthrough Device Designation by the ... to keep up to date on the latest research news and scientific discoveries.